What is Enlivex Therapeutics Ltd?
, together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.01M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.